Network Lead Academic Participating Site Grant from the Roswell Park Cancer Institute
- Institution
- ROSWELL PARK CANCER INSTITUTE CORP, NY
- Principal investigator
- Ellis G Levine
- Funding
- $306K
- Duration
- 2019–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY The Roswell Park Comprehensive Cancer Center (Roswell Park) has had a long tradition of contributing to the national cooperative groups over many decades. Those contributions have been scientific, administrative, and participatory (enrollment on clinical trials). Contributions have been consistent and numerous over the years. This extension briefly summarizes the intent of its 4 PD/PI’s (Levine/Puzanov/Lele/Singh) and the membership of Roswell Park to sustain its commitment to the many strengths inherent to cooperative group research: therapeutic advances; a better understanding of the biology of cancer; cancer prevention; means to improve the quality of life of cancer patients; piloting of new drugs and radiologic and radiation and surgical techniques; establishing the relevance of new cellular and molecular advances to the predictive, prognostic, and therapeutic approaches to patients; and the advancement of patient advocacy. Investigators at Roswell Park and its supporting staff fully recognize the essential importance of the timely and accurate submission of data and specimens to achieve these aims
Research team
- Shashikant LelePI
- Ellis G LevinePI
- Igor PuzanovPI
- Anurag Kishor SinghPI
LOADING MOONBASE SCORE
Questions for ROSWELL PARK CANCER INSTITUTE CORP
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Roswell Park Cancer Institute Corp69
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation
Brian C Betts · $712K · 2023–2028
- NIH · Roswell Park Cancer Institute Corp46
Leveraging the GTP Biosynthetic Pathway for Anti-Tumor Therapies
Anna Bianchi-Smiraglia · $384K · 2020–2026
- NIH · Roswell Park Cancer Institute CorpNot yet scored
A scalable cruciferous vegetable intervention to reduce bladder cancer recurrence and progression
Li Tang · $717K · 2025–2029